Jason Haas's Net Worth

$426 Thousand

Estimate Recalculated Apr 26, 2024 05:37PM EST

Who is Jason Haas?

Jason Haas does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Syros Pharmaceuticals, Inc., and LIGAND PHARMACEUTICALS INC.

SEC CIK

Jason Haas's CIK is 0001883821

Past Insider Trading and Trends

2022 was Jason Haas's most active year for acquiring shares with 6 total transactions. Jason Haas's most active month to acquire stocks was the month of May. 2023 was Jason Haas's most active year for disposing of shares, totalling 4 transactions. Jason Haas's most active month to dispose stocks was the month of February. 2021 saw Jason Haas paying a total of $0.00 for 750,000 shares, this is the most they've acquired in one year. In 2023 Jason Haas cashed out on 27,799 shares for a total of $15,595.56, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $7.185

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+75.99%
10.6K
$5.12
-$24,227.84
24.55K
Mar 31 - Apr 1
Form 4
+913.14%
12.57K
$2.22
-$13,988.22
13.95K
Oct 31 - Nov 1
Form 4
∞
1.38K
$2.58
-$1,607.34
1.38K
Mar 31 - Apr 3
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
—
—
0
Oct 12
Form 3
—
0
—
—
0
No matching records found

LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $74.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+38.03%
1.14K
—
—
4.14K
Jun 9
Form 4
∞
1.75K
—
—
1.75K
Jun 29
Form 3
—
0
—
—
0
No matching records found